glp-1 comparison chart weight loss Is Toujeo a GLP-1? The critical difference explained Oral vs Injectable GLP-1 Drugs:

The win: the Wegovy pill (oral semaglutide 25 mg), launched January 5, 2026, generated $354 million in its first full quarter, doubling analyst estimates

The incidence and severity of these Retatrutide side effects often correlate with dose escalation

These are tiny sample sizes by medical research standards

In 2025, the MHRA reported the seizure of more than 5,000 illegally traded GLP-1 pens

A major meta-analysis finds that patients who discontinue anti-obesity medications quickly regain weight, yet, crucially, they still retain some of their original weight loss a year later, spotlighting the challenges and promise of long-term obesity treatment

Market Problems Arising Unlike FDA-approved drugs, compounded medications are not subject to the same rigorous testing for safety, quality, and efficacy